Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

GP > Statins > Flashcards

Statins Flashcards

1
Q

What is the mechanism of action of statins?

A

Inhibit the action of HMG-CoA reductase, the rate limiting enzyme in hepatic cholesterol synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are 3 key adverse effects of statins?

A
  1. Myopathy: myalgia, myositis, rhabdomyolysis and asymptomatic raised creatine kinase
  2. Liver impairment
  3. May increase risk of intracerebral haemorrhage in those who’ve previously had a stroke
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are 5 risk factors for myopathy (myalgias, rhabdomyolysis) when taking statins?

A
  1. Advanced age
  2. Female sex
  3. Low BMI
  4. Presence of multisystem disease e.g. diabetes mellitus
  5. More common in lipophilic statins (simvastatins, atorvastatin) than relatively hydrophilic (rosuvastatin, pravastatin, fluvastatin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What monitoring is recommended when prescribing statins?

A
  • LFTs: baseline, 3 months and 12 months
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When should treatment with statins be discontinued based on monitoring blood tests?

A

If serum transaminase (LFTs essentially) concentrations rise to and persist at 3 times the upper limit of the reference range

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are 3 contraindications to statins?

A
  1. Avoid in patients with history of intracerebral haemorrhage - risk of recurrence
  2. Macrolides (e.g. erythromycin, clarithromycin) - important interaction, stop statins until course completed
  3. Pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are 4 groups of people who should receive a statin?

A
  1. All people with established cardiovascular disease: stroke, TIA, ischaemic heart disease, peripheral arterial disease
  2. Anyone with 10 year cardiovascular risk >10% (QRISK)
  3. Assess pts with T2DM with QRISK2 to determine whether to start
  4. T1DM diagnosed > 10 years ago OR aged >40y OR have established nephropathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When should statins be taken and why?

A

At night - when the majority of cholesterol synthesis takes place

especially true for simvastatin - shorter half life than others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What statin type and dose is recommended for primary and secondary prevention of cardiovascular disease?

A
  1. Atorvastatin 20mg od for primary prevention
    • Increase dose if non-HDL has not fallen by >40% up to 80mg
  • Atorvastatin 80mg od for secondary prevention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What 2 categories can treatment with statins be divided into?

A
  1. Primary prevention of CVD
  2. Secondary prevention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are 3 scenarios when statins are used for primary prevention of CVD?

A
  1. 10-year cardiovascular risk >10%
  2. most type 1 diabetics
  3. CKD if eGFR <60
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are 3 examples of when statins can be used for secondary prevention of CVD?

A
  1. Known ischaemic heart disease
  2. Cerebrovascular disease
  3. Peripheral arterial disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

At what age should you start to assess for QRISK and therefore treatment with statins?

A

40 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the maximum age at which to use QRISK2 for CVD risk assessment and why?

A

84; >85 years are at high risk due to age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are 3 patient groups in whom the QRISK2 assessment tool should not be used and why?

A
  1. type 1 diabetics
  2. patients with an estimated glomerular filtration rate (eGFR) less than 60ml/min and/or albuminuria
  3. patients with a history of familial hyperlipidaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are 4 patient groups in whom the QRISK2 assessment may underestimate CVD risk?

A
  1. people treated for HIV
  2. people with serious mental health problems
  3. people taking medicines that can cause dyslipidaemia such as antipsychotics, corticosteroids or immunosuppressant drugs
  4. people with autoimmune disorders/ systemic inflammatory disorders such as SLE
17
Q

What blood test should be checked before starting a statin and why?

A

NON-fasting full lipid profile, including triglycerides

Looking at total cholesterol : high-density lipoprotein ratio

18
Q

When should familial hyperlipidaemia be suspected and what should be done?

A

total cholesterol concentration >7.5mmol/l and there is family history of premature coronary heart disease

total cholesterol >9.0 mmol/l or non-HDL cholesterol of >7.5 mmol/l even in absence of first degree family history of premature coronary heart disease

if this is the case - refer

19
Q

Should you start a statin straight away if QRISK2 >10%?

A

Recommend we give patients option of having CVD risk reassessed after period of time before starting a statin

20
Q

What are 4 groups of type 1 diabetics who should be offered a statin?

A
  1. >40 years old
  2. Have had diabetes for more than 10y
  3. have established nephropathy
  4. have other CVD risk factors
21
Q

How are statins used in chronic kidney disease?

A
  • Atorvastatin 20mg offered; increase dose if greater than 40% reduction in non-HDL cholesterol not achieved and eGFR >30ml/min.
  • If eGFR <30ml/min renal specialist should be consulted before increasing dose
22
Q

What follow-up should be performed when people started on statins?

A
  • at 3 months, repeat full lipid profile
  • if non-HDL cholesterol has not fallen by at least 40%, concordance and lifestyle changes should be discussed with patient
  • consider increasing to 80mg
23
Q

What are 10 elements of a cardioprotective diet - a form of lifestyle modification for hyperlipidaemia?

A
  1. total fat intake should be <30% of total energy intake
  2. saturated fats should be <7% of total energy intake
  3. intake of dietary cholesterol should be <300mg/day
  4. saturated fats should be replaced by monounsaturated and polyunsaturated fats where possible
  5. replace saturated and monounsaturated fat intake with olive oil, rapeseed oil or spreads based on these oils
  6. choose wholegrain varieties of starchy food
  7. reduce their intake of sugar and food products containing refined sugars including fructose
  8. eat at least 5 portions of fruit and veg a day
  9. 2 portions of fish per week, including portion of oily fish
  10. eat at least 4-5 portions of unsalted nus, seeds and legumes / week
24
Q

What are the recommendations for physical activity to advise patients with hyperlipidaemia? 2 points

A
  1. aim for at least 150 min moderate intensity aerobic activity or 75 minutes of vigorous intensity aerobic activity or mix of moderate and vigorous
  2. muscle strenghtening activities on 2 or more days a week that work all major muscle groups (legs, hips, back, abdomen, chest, shoulders and arms) in line with national guidance for genearl population
25
Q

What are 3 elements of the alcohol guidelines?

A
  1. No more than 14 units a week for men and women
  2. Spread evenly over 3 or more days
  3. Good to have several alcohol free days
26
Q

Overall what are 4 lifestyle points to advise patients on with hyperlipidaemia?

A
  1. Exercise
  2. Cardioprotective diet
  3. Alcohol
  4. Stop smoking

GP (43 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions